MEDICAL ADVOCATES
 WOMEN AND HIV RESOURCE CENTER
  HIV Clinical Management
 
General Reports
ART Drugs
HAART
Diagnostics/Monitoring


 


 
Women abd HIV Main Page Main New and Noteworthy Home Page

Last Update:  February 28, 2015
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports
Additional HIV Management Reports are Indexed under Applicable National Web Pages
General Reports  

     Journal Papers, Abstracts, and Commentaries
 
 
The successful use of lipectomy in the management of airway obstruction in a woman with HIV-associated lipodystrophy.
Tsui E, Bogdasarian R, Blomain E.
MJ Case Rep. 2015 Feb 18;201
 Abstract

Women, Aging, and HIV: Clinical Issues and Management Strategies.
Womack JA, Brandt CA, Justice AC.
J Nurse Pract. 2014 Jun 1;10(6):409-416.
 Abstract

A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT PDF COMMENTARY
Asking the right questions: developing evidence-based strategies for treating HIV
in women and children
l Karim QA, Banegura A,  Cahn P,  et al
BMC Public Health 2011, 11:388
 Paper

Pill Taking From the Perspective of HIV-Infected Women Who Are Vulnerable to Antiretroviral Treatment Failure.
Stevens PE, Hildebrandt E.  
Qual Health Res. 2009 Mar 3
 Abstract
 
Gender differences in the diagnosis and treatment of HIV.
 Squires KE. 
Gend Med. 2007 Dec;4(4):294-307.
 Abstract

Women and human immunodeficiency virus: unique management issues.
Clark RA, Dumesre J.
Am J Med Sci. 2004 Jul;328(1):17-25.
 Abstract

Total Lymphocyte Count, Hemoglobin, and Delayed-Type Hypersensitivity as
Predictors of Death and AIDS Illness in HIV-1–Infected Women Receiving Highly
Active Antiretroviral Therapy.
Anastos K, Shi Q, French AL, et al
J Acquir Immune Defic Syndr. 2004 Apr 20;35(4):383-392.
 Abstract
ART Drugs
 
General Reports
 
     Journal Papers, Abstracts, and Commentaries
 
  Analysis of endoplasmic reticulum stress in placentas of HIV-infected women treated with protease inhibitors.
Brüning A, Kimmich T, Brem GJ,  et al
Reprod Toxicol. 2014 Dec;50:122-8.
 Abstract

What do we know about antiretroviral treatment of HIV in women?
Monforte Ad, Anderson J, Olczak A.
Antivir Ther. 2013;18 Suppl 2:27-34.
Abstract

Abacavir
 
     Journal Papers, Abstracts, and Commentaries
 
  Abacavir alters the transcription of inflammatory cytokines in virologically suppressed,
HIV-infected women.
 Macleod IJ, Rowley CF, Lockman S, et al
J Int AIDS Soc. 2012 Jul 10;15(2):1-8.
Abstract
 
Acylovir
 
     Conference Reports, Abstracts, and Posters
 
  Characterization of a new use for acyclovir and tenofovir using human cervico-vaginal tissue ex vivo
C. Vanpouile, A. Introini, A. Lisco,  et al
 (7TH IAS Conference on HIV Pathogenesis, Treatment and Prevention)
 Abstract
 
Atazanavir
 
     Journal Papers, Abstracts, and Commentaries
 
  Simultaneous plasma and genital pharmacokinetics and pharmacodynamics of atazanavir and efavirenz in HIV-infected women starting therapy.
Neely M, Louie S, Xu J,  et al
J Clin Pharmacol. 2015 Feb 12
Abstract

Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy.
DuBois BN, Atrio J, Stanczyk FZ, Cherala G.
 Contraception. 2014 Aug 30.
 Abstract

A systematic review of the use of atazanavir in women infected with HIV type-1.
Johnson M, Walmsley S, Haberl A.
Antivir Ther. 2014 Jan 31.
Abstract

Dapivirine
 
     Journal Papers, Abstracts, and Commentaries
 
  Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysis.
 Parsons TL, Emory JF, Seserko LA,  et al J
 Pharm Biomed Anal. 2014 Sep;98:407-16.
 Abstract

Dolutegravir
 
     Journal Papers, Abstracts, and Commentaries
 
  Single and multiple dose pharmacokinetics of dolutegravir in the genital tract of HIV negative women.
Adams JL, Patterson KB, Prince HM,  et al
Antivir Ther. 2013 Jul 31.
 Abstract

Efavirenz

     Journal Papers, Abstracts, and Commentaries
 
 

 

 

 

 Simultaneous plasma and genital pharmacokinetics and pharmacodynamics of atazanavir and efavirenz in HIV-infected women starting therapy.
Neely M, Louie S, Xu J,  et al
J Clin Pharmacol. 2015 Feb 12
Abstract

Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women.
Vieira CS, Bahamondes MV, de Souza RM,  et al
J Acquir Immune Defic Syndr. 2014 May 4.
Abstract

A WEEK-IN-REVIEW FEATURED REPORT 
Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels
when co-administered with combined oral contraceptives.
 Landolt NK, Phanuphak N, Ubolyam S, et al
J Acquir Immune Defic Syndr. 2012 Nov 26
 Abstract

FULL-TEXT ARTICLE
 Efavirenz conceptions and regimen management in a prospective cohort of women on antiretroviral therapy.
 Schwartz S, Taha TE, Venter WD, et al
Infect Dis Obstet Gynecol. 2012;2012:723096
 Paper
.
Nevirapine versus efavirenz in 742 patients: no link of liver toxicity with female sex,
and a baseline CD4 cell count greater than 250 cells/mul
 Manfredi R, Calza L.  
AIDS. 2006 Nov 14;20(17):2233-2236.
Abstract
 
Elvitegravir/Tenofovir/Emtricitabine/Cobicistat

     Conference Reports, Abstracts, and Posters
 
  Two cases of breast tenderness and female hormone fluctuations in women of child-bearing age starting Stribild (FTC/TDF/COBI/ELV)
 S. Scholand, R.D. Bruce
 (7th IAS Conference)
 Abstract

Etravirine

     Journal Papers, Abstracts, and Commentaries
 
  Etravirine Concentrations in the Cervico-Vaginal Compartment in HIV-1 infected Women receiving
Etravirine-containing antiretroviral therapy: DIVA 02 study.
 Clavel C, Peytavin G, Tubiana R,  et al 
Antimicrob Agents Chemother. 2012 Apr 23.
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
  Etravirine penetration in cervicovaginal compartment exceed the median inhibitory concentration
in HIV-1 infected women treated with etravirine-containing regimen (DIVA-02 study)
C. Clavel, G. Peytavin, R. Tubiana, et al
 (6th IAS Conference)
 Abstract
 
Lopinavir/Ritonavir
 
     Journal Papers, Abstracts, and Commentaries
 
  Depot Medroxyprogesterone Acetate (DMPA) in Combination with Twice Daily Lopinavir/Ritonavir-Based Regimen in HIV-Infected Women:
Effective Contraception, Lack of Clinically Significant Interactions, with Good Safety and Tolerability: Results of ACTG 5283.
Luque AE, Cohn SE, Park JG, et al
Antimicrob Agents Chemother. 2015 Jan 26.
Abstract

Lopinavir/ritonavir in human immunodeficiency virus-infected women.
Téllez MJ.
 Enferm Infecc Microbiol Clin. 2014 Nov;32 Suppl 3:22-5.
 Abstract

Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women.
Vieira CS, Bahamondes MV, de Souza RM,  et al
J Acquir Immune Defic Syndr. 2014 May 4.
Abstract

Cost-effectiveness of atazanavir+ritonavir (ATV+RTV) vs. lopinavir/ritonavir (LPV/r) in women of childbearing age in the United Kingdom.
 Simpson K, Kirbach S, Van de Steen O, Gooch K.
J  Int AIDS Soc. 2012 Nov 11;15(6):18385
 Abstract

Meta-Analysis of the Safety, Tolerability, and Efficacy of Lopinavir/Ritonavir-Containing Antiretroviral Therapy in HIV-1-Infected Women.
 Hermes A, Squires K, Fredrick L, et al
HIV Clin Trials. 2012 Nov-Dec;13(6):308-23.
Abstract
 
Maraviroc
 
     Journal Papers, Abstracts, and Commentaries
 
  Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysis.
 Parsons TL, Emory JF, Seserko LA,  et al
J Pharm Biomed Anal. 2014 Sep;98:407-16.
Abstract

Nevirapine

 
     Journal Papers, Abstracts, and Commentaries
 
  Nevirapine (NVP) pharmacokinetics (PK) and risk of rash and hepatitis among HIV-infected Sub-Saharan
African Women.
 Dong BJ, Zheng Y, Hughes MD, et al
AIDS. 2012 Feb 1
 Abstract

Raltegravir

     Journal Papers, Abstracts, and Commentaries
 
  Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.
Lake J, McComsey G, Hulgan T,  et al
HIV Med. 2014 Feb 10.
Abstract

Raltegravir Concentrations in the Genital Tract of HIV-1 infected Women Treated with a
raltegravir containing Regimen : DIVA 01 study
Clavel C, Peytavin G, Tubiana R, et al
Antimicrob Agents Chemother. 2011 Mar 28.
Abstract
 
     Conference Reports, Abstracts, and Posters
 
 

Raltegravir as replacement for PI- or NNRTI-based ART in HIV-infected women with lipohypertrophy: the women,
integrase, and fat accumulation trial
J. Lake, G.A. McComsey, T. Hulgan, et al
 (6th IAS Conference)
 Abstract
 
Saquinavir
 
     Journal Papers, Abstracts, and Commentaries
 
  Pharmacokinetic Study of Saquinavir 500 mg Plus Ritonavir (1000/100 mg Twice a Day) in
HIV-Positive Pregnant Women.
Martinez-Rebollar M, Lonca M, Perez I, et al
 Ther Drug Monit. 2011 Dec;33(6):772-7
 Abstract

Tenofovir

     Journal Papers, Abstracts, and Commentaries
 
  Effects of Tenofovir on Cytokines and Nucleotidases in HIV-1 Target Cells and the Mucosal Tissue Environment in the Female Reproductive Tract.
Biswas N, Rodriguez-Garcia M, Shen Z, et al
Antimicrob Agents Chemother. 2014 Aug 18.
Abstract

FULL-TEXT ARTICLE
 Sex Hormones Regulate Tenofovir-Diphosphate in Female Reproductive Tract Cells in Culture.
Shen Z, Fahey JV, Bodwell JE,  et al
PLoS One. 2014 Jun 30;9(6):e100863.
Paper

FULL-TEXT ARTICLE
 Cervical Cancer Precursors and Hormonal Contraceptive Use in HIV-Positive Women: Application of a Causal Model and Semi-Parametric Estimation Methods.
Leslie HH, Karasek DA, Harris LF, et al  
PLoS One. 2014 Jun 30;9(6):e101090.
Paper
Sensitive Tenofovir Resistance Screening of HIV-1 from the Genital and Blood Compartments of Women with Breakthrough Infections
in the CAPRISA 004 Tenofovir Gel Trial.
Wei X, Hunt G, Karim SS,  et al
J Infect Dis. 2014 Jan 16
 Abstract

A WEEK-IN REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
 Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events.
Gervasoni C, Meraviglia P, Landonio S,et al 
PLoS One. 2013 Dec 2;8(12):e80242
 Paper

Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics
in a large cohort of HIV-infected women.
 Baxi SM, Greenblatt RM, Bacchetti P, et al
AIDS. 2013 Nov 23.
 Abstract

An Evaluation of Polycaprolactone Matrices for Vaginal Delivery of the Antiviral, Tenofovir, in Preventing Heterosexual Transmission of HIV.
 Dang NT, Sivakumaran H, Harrich D, Coombes AG.
 J Pharm Sci. 2013 Jul 31
 Abstract

A WEEK-IN REVIEW FEATURED REPORT
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV-infected women.
Garlassi E, Zona S, Vescini F,  et al
J Int AIDS Soc. 2012 Nov 11;15(6):18317.
Abstract

Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS).
Oboho I, Abraham A, Benning L, et al
 J Acquir Immune Defic Syndr. 2012 Dec 18.
Abstract

Simultaneous Delivery of Tenofovir and Acyclovir via an Intravaginal Ring.
 Moss JA, Malone AM, Smith TJ,  et al
Antimicrob Agents Chemother. 2011 Nov 28.
Abstract
 
    Conference Reports, Abstracts, and Posters
 
  Characterization of a new use for acyclovir and tenofovir using human cervico-vaginal tissue ex vivo
C. Vanpouile, A. Introini, A. Lisco,  et al
 (7TH IAS Conference on HIV Pathogenesis, Treatment and Prevention)
 Abstract
 
Tenofovir/Emtricitabine
 
     Journal Papers, Abstracts, and Commentaries
 
  FULL-TEXT ARTICLE
 Cervical Cancer Precursors and Hormonal Contraceptive Use in HIV-Positive Women: Application of a Causal Model and Semi-Parametric Estimation Methods.
Leslie HH, Karasek DA, Harris LF, et al  
PLoS One. 2014 Jun 30;9(6):e101090.
Paper
HAART/ART
Additional HAART Reports are Indexed under Applicable National Web Pages
General Reports

    Journal Papers, Abstracts, and Commentaries
 
 
Optimizing antiretroviral therapy for women living with HIV.
Greig JM, Anderson J.
Curr Opin Infect Dis. 2014 Feb;27(1):46-52
 Abstract

Increase in Single Tablet Regimen Use and Associated Improvements in Adherence -Related Outcomes in HIV-Infected Women
 Hanna DB, Hessol NA, Golub ET, et al
J Acquir Immune Defic Syndr. 2013 Dec 8
 Abstract

Optimizing antiretroviral therapy for women living with HIV.
Greig JM, Anderson
J.Curr Opin Infect Dis. 2013 Dec 7
 Abstract

Relationship Between Poor Physical Function, Inflammatory Markers, and Comorbidities in HIV-Infected Women on Antiretroviral Therapy.
Baranoski AS, Harris A, Michaels D,
J Womens Health (Larchmt). 2013 Nov 12.
 Abstract

Effects of pill burden on discontinuation of the initial HAART regimen in minority female patients prescribed 1 pill/day versus any other pill burden.
 Hill S, Kavookjian J, Qian J,  et al
AIDS Care. 2013 Oct 10.
 Abstract

Improvements in virological control among women conceiving on cART in Western Europe.
Bailey H, Townsend CL, Cortina-Borja M,  et al
AIDS. 2013 Jun 3
 Abstract

FULL-TEXT PDF ARTICLE
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study.
Loutfy MR, Walmsley SL, Klein MB,  et al
BMC Infect Dis. 2013 Jun 3;13(1):256
 Paper

Associations of cardiovascular variables and HAART with cognition in middle-aged HIV-infected
and uninfected women.
Crystal HA, Weedon J, Holman S, et al
J Neurovirol. 2011 Oct 18
 Abstract

Lack of effect of compartmentalized drug resistance mutations on HIV-1 pol divergence
in antiretroviral-experienced women.
Kelley CF, Sullivan ST, Lennox JL, et al 
AIDS. 2010 Apr 12.
 Abstract

Treatment Responses in Antiretroviral Treatment-Naive Premenopausal and Postmenopausal
HIV-1-Infected Women: An Analysis from AIDS Clinical Trials Group Studies.
Patterson KB, Cohn SE, Uyanik J, et al
Clin Infect Dis. 2009 Jun 25
 Abstract

Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort
of HIV-infected women.
Gandhi M, Benet LZ, Bacchetti P, et al 
J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):482-91
 Abstract

Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives.
 El-Ibiary SY, Cocohoba JM.
Eur J Contracept Reprod Health Care. 2008 Jun;13(2):123-32.
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
 Patterns, predictors, and consequences of initial regimen type among HIV-infected
women receiving highly active antiretroviral therapy.
 Golub ET, Benning L, Sharma A, et al
Clin Infect Dis. 2008 Jan 15;46(2):305-12
 Abstract
 
Consistency of Initial Antiretroviral Therapy With HIV Treatment Guidelines in a US Cohort of
HIV-Infected Women.
 Cocohoba J, Wang QJ, Cox C, et al
J Acquir Immune Defic Syndr. 2007 Dec 20
Abstract
 
FULL-TEXT PDF ARTICLE
 Assessing the effect of HAART on quality of life among HIV-infected women.
Liu C, Weber K, Robison E, Hu Z, et al 
AIDS Res Ther. 2006 Mar 20;3(1):6 [
 Paper
 
A WEEK-IN-REVIEW FEATURED REPORT
Factors Associated with Poor Immunologic Response to Virologic Suppression by Highly
Active Antiretroviral Therapy in HIV-Infected Women.
Vaamonde CM, Hoover DR, Anastos K, et al 
AIDS Res Hum Retroviruses. 2006 Mar;22(3):222-31.
 Abstract

Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the
Women's Interagency HIV Study.
Silverberg MJ, Gore ME, French AL, et al
Clin Infect Dis. 2004 Sep 1;39(5):717-24
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
 

Genital secretions of HIV-1 infected women on effective antiretroviral therapy contain high drug concentrations and low amounts of
cell-free virus
A. Sheth, T. Evans-Strickfaden, A. Martin, et al
 (6th IAS Conference)
 Abstract

POSTER
 Stavudine toxicity in women is the main reason for treatment change in a 3 year
prospective cohort of adult patients started on first line antiretroviral treatment (ART)
in Uganda
B. Castelnuovo, A. Kiragga, M. Kamya, et al
(5th IAS Conference)
 PDF Poster     Abstract

The association of perception of body fat changes with HAART adherence in the women’s
interagency HIV study
 Plankey M, Bacchetti P, Jin C, et al
 (4th IAS Conference)
 Abstract
 


Adherence   

          Journal Papers, Abstracts, and Commentaries

 
An investigation of the possible interaction between the use of Vitamin C and highly active antiretroviral therapy (HAART) adherence and effectiveness in treated HIV+ women.
Merenstein D, Wang C, Gandhi M, et al
Complement Ther Med. 2012 Aug;20(4):222-7
 Abstract

Recent Trauma is Associated with Antiretroviral Failure and HIV Transmission Risk Behavior Among
HIV-Positive Women and Female-Identified Transgenders.
Machtinger EL, Haberer JE, Wilson TC, Weiss DS.
AIDS Behav. 2012 Mar 17.
Abstract

Women and Vulnerability to HAART Non-Adherence: A Literature Review of Treatment Adherence by Gender from 2000 to 2011.
Puskas CM, Forrest JI, Parashar S, et al
Curr HIV/AIDS Rep. 2011 Oct 12
 Abstract

Association of Child Care Burden and Household Composition with Adherence to Highly Active
Antiretroviral Therapy in the Women's Interagency HIV Study.
 Merenstein D, Schneider MF, Cox C, et al
AIDS Patient Care STDS. 2009 Feb 25.
 Abstract
 
Association Between Living With Children and Adherence to Highly Active Antiretroviral Therapy
in the Women's Interagency HIV Study.
 Merenstein DJ, Schneider MF, Cox C, et al
Pediatrics. 2008 Apr;121(4):e787-93.
 Abstract
 
In or out? Methodological considerations for including and excluding findings from a
meta-analysis of predictors of antiretroviral adherence in HIV-positive women.
Voils CI, Barroso J, Hasselblad V, Sandelowski M. 
J Adv Nurs. 2007 Jun 3;
 Abstract

Illicit drug use, depression and their association with highly active antiretroviral therapy
in HIV-positive women.
Cook JA, Grey DD, Burke-Miller JK, et al
Drug Alcohol Depend. 2007 Feb 7;
 Abstract
 
Efficacy of a Group Medication Adherence Intervention Among HIV Positive Women:
The SMART/EST Women's Project
Jones DL, McPherson-Baker S
AIDS Behav. 2006 Sep 21
 Abstract
 
Sleep Disturbance and Depression as Barriers to Adherence.
 Phillips KD, Moneyham L, Murdaugh C, et al 
Clin Nurs Res. 2005 Aug;14(3):273-293.
 Abstract
 
Medication adherence for HIV positive women caring for children: in their own words.
Wood SA, Tobias C, McCree J.
AIDS Care. 2004 Sep;16(7):909-13.
Abstract
 
Adherence to antiretroviral medications in hiv/aids care: a narrative exploration of one
woman's foray into intentional nonadherence.
 Johnston Roberts K, Mann T.
Health Care Women Int. 2003 Jul-Aug;24(6):552-64.
Abstract

Home-based study of anti-HIV drug regimen adherence among HIV-infected women:
feasibility and preliminary results.
Durante AJ, Bova CA, Fennie KP, et al
 AIDS Care 2003 Feb;15(1):103-15
 Abstract

Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV
|infection: a preliminary study.
 Demas PA, Webber MP, Schoenbaum EE, et al.
 Pediatrics 2002 Sep;110(3):e35
 Abstract

Adherence to antiretroviral therapy among women with HIV infection.
 Erlen JA, Sereika SM, Cook RL, Hunt SC.
 J Obstet Gynecol Neonatal Nurs 2002 Jul-Aug;31(4):470-7
 Abstract

Adherence discourse among African-American women taking HAART.
 Sankar A, Luborsky M, Schuman P, Roberts G.
 AIDS Care 2002 Apr;14(2):203-18
 Abstract

Adherence to antiretroviral therapy and its association with sexual behavior in a national
sample of women with human immunodeficiency virus.
 Wilson TE, Barron Y, Cohen M, et al.
 Clin Infect Dis 2002 Feb 15;34(4):529-34
 Abstract
 

  
     Conference Reports, Abstracts, and Posters
 
  Improved adherence to HAART among a cohort of non-pregnant women and its
associated factors
C D Zorrilla, L E Santiago, M Acevedo, et al
 (15IAC)
 Abstract
 
Using directly delivered therapy (DDT) to improve ART adherence among urban indigent women
M B Nykyforchyn, G Morgan, L Laufman, et al
(15IAC)
 Abstract
 
Resistance

    Journal Papers, Abstracts, and Commentaries
 
 
HIV-1 Drug Resistance in Variants from the Female Genital Tract and Plasma
Kemal KS, Burger H, Mayers D, et al 
J Infect Dis. 2007 Feb 15;195(4):535-45.
 Abstract
 
Genotypic Resistance and Immunologic Outcomes Among HIV-1-Infected Women With
Viral Failure.
 Gange SJ, Schneider MF, Grant RM, et al  
J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):68-74.
Abstract

Differential evolution of cell-associated virus in blood and genital tract of HIV-infected
females undergoing HAART.
Tirado G, Jove G, Reyes E,, et al  
Rev Med SuVirology. 2005 Apr 10;334(2):299-305.
 Abstract
 
Treatment Discontinuation/Interruption

    Journal Papers, Abstracts, and Commentaries

  Factors and Temporal Trends Associated With Highly Active Antiretroviral Therapy
Discontinuation in the Women's Interagency HIV Study.
 Ahdieh-Grant L, Tarwater PM, Schneider MF, et al 
J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):500-503.
Abstract

     Conference Reports, Abstracts, and Posters
 
  Prevalence and predictors of treatment interruptions in a longitudinal cohort study
in women
M Gandhi, N Ameli, T Liegler, R Grant, et al
(15IAC)
 Abstract
 
Adverse Events

    Journal Papers, Abstracts, and Commentaries
 
 
Changes in Body Mass Index Following HAART Initiation among HIV-Infected Women in the Women's Interagency HIV Study.
Sharma A, Bynum SA, Schneider MF,  et al
J AIDS Clin Res. 2014;5.
Abstract

The Impact of Kidney Function at Highly Active Antiretroviral Therapy Initiation on Mortality in
HIV-Infected Women.
Estrella MM, Parekh RS, Abraham A,  et al
J Acquir Immune Defic Syndr. 2010 Jun 25
 Abstract

Effect of Non-Nucleoside Reverse Transcriptase Inhibitors on Cytokine, Chemokine,
and Immunoglobulin Profiles in Serum and Genital Secretions of HIV-Infected Women.
Sachdeva RK, Wanchu A, Bagga R, Malla N, Sharma M.
J Interferon Cytokine Res. 2010 Feb 28
 Abstract

Highly active antiretroviral therapy and incidence of cervical squamous
intraepithelial lesions among HIV-infected women with normal cytology
and CD4 counts above 350 cells/mm3.
 Sirera G, Videla S, López-Blázquez R, et al
J Antimicrob Chemother. 2007 Oct 31;
 Abstract

Antiretroviral Therapies Associated with Lipoatrophy in HIV-Infected Women.
Tien PC, Barron Y, Justman JE, et al
 AIDS Patient Care STDS. 2007 May;21(5):297-305
 Abstract
Diagnostics/Monitoring
 
     Journal Papers, Abstracts, and Commentaries
 
  Cheminformatics Analysis to Identify Predictors of Antiviral Drug Penetration into the Female Genital Tract.
Thompson C, Sedykh A, Nicol M,  et al
AIDS Res Hum Retroviruses. 2014
Abstract

Quantification of Genital HIV-1 DNA in Women with Low Plasma HIV-1 RNA Levels
Typical of HIV-1 Non-Transmitters.
Benki S, McClelland RS, Emery S, et al
J Clin Microbiol. 2006 Oct 18;
Abstract

Women abd HIV Main Page Main New and Noteworthy Home Page

HIV Clinical Management